To accelerate MS cures, the National MS Society is convening scientific, medical and public health leaders to contribute to the most promising pathways to cures and to cultivate global collaboration in pursuit of cures.
Mark Allegretta, PhD – National MS Society Sergio Baranzini, PhD – University of California, San Francisco Amit Bar-Or, MD – University of Pennsylvania, Philadelphia Lisa Barcellos, PhD, MPH – University of California Berkeley Bruce F. Bebo, PhD – National MS Society Fiona Brabazon, PhD – National MS Society Timothy Coetzee, PhD – National MS Society Philip De Jager, MD, PhD – Columbia University, New York Robin Franklin, PhD – University of Cambridge, Cambridge Vitorio Gallo, PhD – The Children’s National Medical Center, Washington, DC Gavin Giovanonni, MD, PhD – Queen Mary University of London, London Jennifer Graves, MD, PhD – University of California, San Diego Walter A. Kostich, PhD – National MS Society Douglas Landsman, PhD – National MS Society Amy Lovett-Racke, PhD – Ohio State University Medical Center, Columbus Ruth Ann Marrie, MD, PhD – University of Manitoba, Winnipeg Kelly R. Monk, PhD – Oregon Health and Science University, Portland Kassandra Munger, ScD – Harvard T.H. Chan School of Public Health, Boston Alexander V. Ng, PhD – Marquette University, Milwaukee Daniel Ontaneda, MD, PhD – Cleveland Clinic, Cleveland Michelle Ploughman, PhD – Memorial University of Newfoundland, St John's Kathryn Smith – KES Business Consulting, LLC, Lyme, CT Caroline C. Whitacre, PhD – National MS Society Terry Wood, PhD – Rutgers New Jersey Medical School, Newark Kathleen Zackowski, PhD, OTR – National MS Society —on behalf of the National MS Society’s Scientific Advisory Committee and Pathways to Cures Roadmap Task Force